Search Results
Oct 24, 2025, 12:18 ET 再鼎醫藥公布Zocilurtatug Pelitecan（前稱ZL-1310）最新一期臨床數據， 顯示其成為同類首創用於小細胞肺癌的靶向DLL3 ADC的潛力，並啟動全球三期注冊研究
泌癌，這兩個項目預計將在明年進入注冊性研究階段。」 本次報告披露了包括1期單藥劑量遞增和劑量擴展階段的共6個劑量組的115例患者（0.8 mg/kg、1.2 mg/kg、1.6 mg/kg、2.0 mg/kg、2.4 mg/kg和2.8 mg/kg）的最新結果，數據截止日為2025年9月15日。其中102例患者至少完成過一次基於實體瘤療效評價標准1.1版（RECIST v1.1）的基線後腫瘤評估。 這項多中心研究的所有入組患者均在含鉑化療後出現疾病進展，90%的患者既往接受過免疫檢查點抑制劑治療後出現疾
More news about: 再鼎醫藥
Oct 24, 2025, 11:38 ET Prêmio Mulheres do Agro 2025 revela iniciativas sustentáveis no agronegócio
social e a sustentabilidade. Já Naiara Kasmin, terceira geração à frente da gestão da Fazenda Campestre, localizada em Varginha (MG), mostra que é possível inovar sem perder a essência. Sua visão empreendedora fez triplicar a produção diária de leite, após uma análise rigorosa de custos
More news about: Bayer
Oct 24, 2025, 09:08 ET Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials
Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials. Glenmark's Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials is bioequivalent and therapeutically
More news about: Glenmark Pharmaceuticals
Oct 24, 2025, 09:02 ET Ortho Molecular Products Partners with Calocurb® to Launch Calocurb® CLINICAL, an Exclusive, Clinically Proven Appetite Management Solution Only Available Under the Guidance of Licensed Practitioners
plant-based appetite and craving control supplement designed specifically for clinical use. Calocurb® CLINICAL delivers a 250 mg therapeutic dose of Amarasate®, a patented natural bitter hops extract developed over 15 years through a $20 million New Zealand government investment
More news about: Calocurb
Oct 24, 2025, 09:00 ET With More Adults Admitting To Celebrating Halloween in 2025, THC Pioneer Delta Beverages Launches New Campaign To Own Spooky Season
are choosing to celebrate." Delta product is available in over 8,500 locations nationwide with variations that include 5mg, 10mg, or 20mg of premium hemp-derived THC. Visit www.drinkdelta.com or see the brand on Instagram @delta.seltzer.
More news about: Delta Beverages
Oct 24, 2025, 07:29 ET Sobi showcases new data across rare inflammatory conditions at ACR 2025
flares that cause intense pain. Approximately 200,000 people in the United States suffer from uncontrolled gout, with serum uric acid (sUA) levels above 6 mg/dL despite treatment with oral urate lowering therapies. This leads to debilitating flares and tophi. Elevated sUA levels have also been associated with
More news about: Swedish Orphan Biovitrum AB
Oct 24, 2025, 06:45 ET Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
receiving baricitinib 4 mg and 31% receiving baricitinib 2 mg achieved successful hair regrowth (defined as 80% or more scalp hair coverage, SALT ≤20)1 41.2% of patients receiving baricitinib 4 mg and 26.2% of patients receiving baricitinib 2 mg achieved near-complete
More news about: Eli Lilly and Company
Oct 24, 2025, 06:45 ET Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
2024. EBGLYSS 250 mg/2 mL injection is dosed as a single monthly maintenance injection following the initial phase of treatment. The recommended initial starting dose of EBGLYSS is 500 mg (two 250 mg injections) at Week 0 and Week 2, followed by 250 mg every two weeks until Week 16 or
More news about: Eli Lilly and Company
Oct 23, 2025, 19:30 ET HanchorBio Presents Phase 1 HCB101 Clinical Results at FACO 2025 Demonstrating Safety and Early Antitumor Activity
levels (0.08-18.00 mg/kg, QW), only one dose-limiting toxicity (DLT) was observed, a transient Grade 3 thrombocytopenia at the 2.56 mg/kg dose level. Consistent receptor occupancy (RO): >90% CD47 RO achieved at doses ≥1.28 mg/kg.
More news about: HanchorBio Inc.
Oct 23, 2025, 13:28 ET ATYR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
corticosteroid (OCS) dose at week 48, with the OCS dose reducing by an average of 2.79mg for 5.0 mg/kg efzofitimod compared to 3.52 mg for placebo. Complete steroid withdrawal was achieved for 52.6% of patients treated with 5.0 mg/kg efzofitimod versus 40.2% on placebo. After aTyr Pharma
More news about: Faruqi & Faruqi, LLP
Oct 23, 2025, 13:22 ET INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
2025, Jasper issued a press release reporting updated data from the BEACON Study. The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed
More news about: Faruqi & Faruqi, LLP
Oct 23, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX
has issued a negative opinion on the request to approve the dosing regimen of 2 mg/kg body weight infused every 4 weeks (E4W) for Elfabrio (pegunigalsidase alfa, in addition to the currently approved dosing regimen of 1 mg/kg body weight infused every 2 weeks (E2W)." On this news,
More news about: Pomerantz LLP
Oct 23, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPR
2025, Jasper issued a press release reporting updated data from the BEACON Study. The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed
More news about: Pomerantz LLP
Oct 23, 2025, 08:37 ET Bragg® Pineapple Turmeric Apple Cider Vinegar Blend Is Launching Into Stores This October
staple with the brightness of organic pineapple and the earthiness of turmeric, a spice renowned for its wellness benefits. Each 16 oz. bottle delivers 750mg of acetic acid per serving and the naturally fermented 'Mother' culture Bragg is known for, now in a taste-forward formula. "At
More news about: Bragg Live Food Products
Oct 23, 2025, 08:00 ET Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
Autoimmune diseases, such as systemic lupus erythematosus (SLE) and myasthenia gravis (MG), affect millions of people worldwide and pose significant public health challenges. These conditions are characterized by the immune system mistakenly
More news about: Ginkgo Bioworks
Oct 23, 2025, 07:00 ET HanchorBio's Novel CD47-SIRPα Therapeutic HCB101 Accepted for Publication in Prestigious Journal of Hematology & Oncology
activity was first observed at 2.56 mg/kg, where evaluable patients achieved SD with modest tumor shrinkage, averaging a 6% reduction in tumor size in the dose cohort. At 5.12 mg/kg, all three evaluable patients achieved confirmed PRs (33%–46% tumor reductions). At 8.0 mg/kg, all three evaluable patients have
More news about: HanchorBio Inc.
Oct 23, 2025, 07:00 ET Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics
group 1 were treated with vehicle control, group 2 were treated with QO (25ug/mouse, i.v., every three days), group 3 were treated with alectinib (0.5mg/kg/mouse, oral gavage, every day) and group 4 were treated with QO and alectinib in combination at the same concentration and frequency of dosing for up
More news about: Genprex, Inc.
Oct 22, 2025, 20:00 ET Harbour BioMed Announces Positive Phase II Results for HBM4003 and Tislelizumab Combination in MSS mCRC
NCT05167071) enrolled 24 heavily pretreated patients with non-liver-metastatic (NLM) MSS mCRC. Patients received HBM4003 (0.3 mg/kg) plus tislelizumab (200 mg) every 21 days. The primary efficacy endpoint was objective response rate (ORR) per RECIST 1.1 criteria. The findings showed promising
More news about: Harbour BioMed
Oct 22, 2025, 18:40 ET Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19.
20% of COVID patients from protease inhibitor treatment. In Phase 1 multiple ascending dose (MAD) studies, a daily oral 600 mg regimen sustained plasma concentrations ~13× above EC50 for the full 10-day course, with trough levels remaining above EC90
More news about: Expert Systems, Inc.
Oct 22, 2025, 18:03 ET South Beach Brewing Company Partners with Global Entrepreneur Rick Ross to Launch THC/CBD-Infused Beverages
drink has 5mg of both THC and CBD. It's a super refreshing blend with real watermelon juice and a cool hint of mint, perfect for unwinding with a crisp, invigorating taste. High Tide: A bolder sip with 10mg of THC
More news about: South Beach Brewing Company
Oct 22, 2025, 16:05 ET Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
were rapidly titrated to 90 mg daily doses. After four weeks of daily dosing at 90 mg, participants were down-titrated to 30 mg daily doses and maintained at 30 mg daily for seven weeks. Weight loss in this treatment group was shown to be rapid and progressive through the 90 mg treatment period and was
More news about: Viking Therapeutics, Inc.
Oct 22, 2025, 14:51 ET Sports Research® Expands Wellness Access with Walmart Nationwide Launch of Sweet Sweat® Gel and Walmart-Exclusive Waist Trimmer
Triple Strength Alaskan Omega-3 Fish Oil: Ultraconcentrated formula with 1,040mg of Omega-3 fatty acids from Wild Alaskan Pollock in just one softgel. Evening Primrose Oil 1300mg with 10% GLA Liquid Softgels: Go-to for supporting women's health and
More news about: Sports Research
Oct 22, 2025, 11:00 ET Psilocybin + Mindfulness Shows Promise for Healthcare Worker Depression: Report
to just 8% who only learned mindfulness practices. The study showed significant sustained improvements in symptoms with a single dose of psilocybin (25mg), administered at week 6 of the meditation course. Most psilocybin studies are expensive and hard to scale up as they use two
More news about: Huntsman Mental Health Institute
Oct 22, 2025, 10:30 ET ACP Bioenergia e Germina Baixio firmam parceria para produção de grãos e algodão em área 100% irrigada no Baixio de Irecê, na Bahia
realizou a primeira safra de cana-de-açúcar em seu polo de Campina Verde (MG) com o grupo Cerradão, alcançando a marca de quatro milhões de toneladas de cana produzidas. Em 2025, a empresa iniciou as operações no polo em Lagoa da Prata (MG), em parceira com o grupo Raízen. Reconhecida
More news about: ACP Bioenergia
Oct 22, 2025, 10:00 ET The Next Adventure Begins: 2026 RAV4 Arrives this Winter
motor-generators (MG1 and MG2) through a planetary-type continuously variable transmission to power the front wheels. The engine, working in concert with the primary electric motor (MG2), assures responsive performance, while exemplary energy efficiency is achieved by using both electric motors (MG1 and MG2) to charge
More news about: Toyota Motor North America